Jian Kang

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

Chen Wang, Jianying Xu, Lan Yang et al. · The Lancet · 2018 · 1.7K citations

Pulmonary Care, Global Health, Risk +5

Prevalence of Chronic Obstructive Pulmonary Disease in China

Nanshan Zhong, Chen Wang, Wan-zhen Yao et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 756 citations

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study

Kewu Huang, Ting Yang, Jianying Xu et al. · The Lancet · 2019 · 724 citations · Full text

Asthma, Environmental Allergy, Allergy +9

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

Jinping Zheng, Jian Kang, Shaoguang Huang et al. · The Lancet · 2008 · 353 citations

Acute Lung Injury, Advanced Lung Disease, Pharmacology +7